[1]赵宏伟.急性脑梗死的危险因素及临床诊治研究[J].医学信息,2019,32(18):44-47.[doi:10.3969/j.issn.1006-1959.2019.17.015]
　ZHAO Hong-wei.Risk Factors and Clinical Diagnosis and Treatment of Acute Cerebral Infarction[J].Journal of Medical Information,2019,32(18):44-47.[doi:10.3969/j.issn.1006-1959.2019.17.015]
点击复制

急性脑梗死的危险因素及临床诊治研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年18期
页码:
44-47
栏目:
综述
出版日期:
2019-09-15

文章信息/Info

Title:
Risk Factors and Clinical Diagnosis and Treatment of Acute Cerebral Infarction
文章编号:
1006-1959（2019）17-0044-04
作者:
赵宏伟
天津市蓟州区人民医院神经内科，天津 301900
Author(s):
ZHAO Hong-wei
Department of Neurology, Tianjin Jizhou District People's Hospital,Tianjin 301900,China
关键词:
急性脑梗死; 诱发因素; 危险因素
Keywords:
Key words：Acute cerebral infarction; Predisposing factors; Risk factors
分类号:
R743.33
DOI:
10.3969/j.issn.1006-1959.2019.17.015
文献标志码:
A
摘要:
急性脑梗死属于临床多发病，近年来其发病率呈现逐年上升趋势，正确认识急性脑梗死的危险因素，积极采取预防及治疗措施，可有效提升患者的生活质量。脑梗死的诱发因素较多，主要包括高血压、高血脂、糖尿病、心血管疾病、感染、吸烟、饮酒等。随着诊疗技术的不断发展，对于急性脑梗死的诊断及治疗方案也在不断更新。本文主要对急性脑梗死相关危险因素及治疗方案进行综述。
Abstract:
Abstract：Acute cerebral infarction is a clinically frequently-occurring disease. In recent years, its incidence rate has been increasing year by year. Correct understanding of the risk factors of acute cerebral infarction and active prevention and treatment measures can effectively improve the quality of life of patients. There are many predisposing factors for cerebral infarction, including hypertension, hyperlipidemia, diabetes, cardiovascular disease, infection, smoking, and drinking. With the continuous development of diagnosis and treatment technology, the diagnosis and treatment plan for acute cerebral infarction is also constantly updated. This article reviews the risk factors and treatment options associated with acute cerebral infarction.

参考文献/References:

[1]吴金飞,陈传琳,曾素琴,等.脑梗死危险因素及生化特征分析[J].东南国防医药,2014,16(3):270-272. [2]Ko JK,Cha SH,Choi CH.Sphenoid Ridge Meningioma Presenting as Acute Cerebral Infarction[J].J Korean Neurosurg Soc,2014,55(2):99-102. [3]?魻cek L,Güner D,Uludag IF1,et al.Risk Factors for Hemorrhagic Transformation in Patients with Acute Middle Cerebral Artery Infarction[J].Noro Psikiyatri Arsivi,2015,52(4):342-345. [4]李旷怡,黄玉萍,张英俭,等.佛山地区急性脑梗死危险因素的病例对照研究[J].中国中医急症,2017,26(10):1711-1713. [5]杜秋明,曹书华,王淑亮,等.高血压患者发生急性脑梗死的影响因素分析[J].中国慢性病预防与控制,2018,26(2):133-137. [6]刘花利,高烨.脑梗死相关危险因素调查分析[J].陕西医学杂志,2017,46(1):130-131. [7]阮晓兰,刘春英.急性脑卒中与脂代谢紊乱的相关性分析[J].脑与神经疾病杂志,2012,20(3):228-230. [8]罗云,李敬伟,王翀,等.糖尿病影响脑梗死的形成与颈动脉斑块相关[J].中华神经医学杂志,2012,11(1):83-86. [9]石冬梅,谭兰.急性脑梗死早期患者血糖水平对预后的影响[J].山东医药,2014,54(23):45-46. [10]吕建庄,葛兴利,郝春媛,等.心血管内科住院患者发生急性脑梗死24例危险因素分析[J].陕西医学杂志,2015,44(10):1432-1433. [11]唐玲,余震,张东平,等.青年型脑梗死危险因素及病因分析[J].检验医学与临床,2016,13(22):3244-3246. [12]叶亚丽,费鲜明.同型半胱氨酸和纤维蛋白原在急性脑梗塞诊断中的应用评价[J].中国卫生检验杂志,2014,12(1):87-89. [13]李明.血清同型半胱氨酸、血浆内皮素-1、B型利钠肽及D-二聚体联合检测对急性脑梗死的诊断价值[J].实用临床医药杂志,2015,19(1):23-25. [14]路小薇.急性脑梗死患者血清炎性因子及血流动力学变化及意义[J].海南医学院学报,2016,22(1):93-95. [15]曹江欣,崔凤珍,张哲,等.64层螺旋CT脑灌注成像在急性脑梗死诊断中的应用[J].临床误诊误治,2016,29(2):78-80. [16]曹兰芳,王建林,杨志秀,等.磁共振弥散加权成像在急性脑梗死诊断中的应用价值[J].解放军预防医学杂志,2018,36(5):627-629,646. [17]张世魁,马娅琼,杨蓉佳,等.128层螺旋CT灌注成像在诊断急性脑梗死及评价患者临床预后的应用价值[J].中国动脉硬化杂志,2015,23(6):603-606. [18]王小乐.CT、MRI对急性脑梗塞患者早期诊断意义比较[J].中国CT和MRI杂志,2016,14(1):15-17. [19]Camerlingo M,Tudose V,Tognozzi M,et al.Predictors of re-canalisation in acute cerebral infarction from occlusion of the terminal internal carotid artery or of the middle cerebral artery mainstem treated with thrombolysis[J].Int J Neurosci,2014,124(3):199-203. [20]赵秀欣,穆利春,马丽芳.rt-PA静脉溶栓治疗急性脑梗死临床分析[J].中国循证心血管医学杂志,2016,8(4):486-488. [21]张璐璐.静脉溶栓对急性脑梗死患者氧化应激反应及神经功能的影响[J].河北医学,2015,48(10):1262-1265. [22]党哲,张国鲁,张微微,等.rt-PA联合尿激酶静脉溶栓治疗急性脑梗死的疗效及安全性研究[J].脑与神经疾病杂志,2014,22(4):287-291. [23]沈明强,吴冠会,董晓峰,等.阿加曲班抗凝治疗急性脑梗死的疗效观察[J].临床神经病学杂志,2017,30(2):141-143. [24]闫喜格,张淑娟,路峰,等.急性脑梗死尿激酶溶栓术后早期抗凝治疗[J].中西医结合心脑血管病杂志,2015,13(11):1329-1331. [25]高峰.抗血小板联合抗凝治疗在脑梗死急性期的应用研究[J].蚌埠医学院学报,2016,41(9):1164-1167. [26]蒲应香,邢成文,李玉鹏,等.阿司匹林联合氯吡格雷治疗急性脑梗死的临床疗效[J].神经损伤与功能重建,2016,11(2):161-162. [27]梁茜茜,张庆,李莉,等.阿司匹林联合氯吡格雷治疗急性脑梗死的临床研究[J].中国临床药理学杂志,2016,32(16):1446-1448. [28]吴学良,刘国江,陈文鑫,等.西洛他唑与氯吡格雷用于急性期脑梗死的抗血小板作用比较[J].实用心脑肺血管病杂志,2015,23(6):67-69. [29]邓有琦,左宏,严建东,等.降纤酶治疗急性脑梗塞的疗效及对血浆纤维蛋白原的影响[J].现代生物医学进展,2016,16(5):919-921. [30]林宝全,阳洪,佘军红,等.降纤酶对急性脑梗死患者血清C反应蛋白、神经功能缺损及凝血时间的影响[J].现代生物医学进展,2016,16(33):6495-6498. [31]贾宝,韩怀志.降纤酶对急性脑梗死患者血清超敏C反应蛋白、D-二聚体及NIHSS评分和Barthel指数的影响[J].海南医学,2016,27(18):2945-2948.

相似文献/References:

[1]冯 湧.新一代抗凝血药阿加曲班的临床应用进展[J].医学信息,2018,31(02):43.[doi:10.3969/j.issn.1006-1959.2018.02.015]
　FENG Yong.Progress in Clinical Application of the New Generation Anticoagulant Agatripine[J].Journal of Medical Information,2018,31(18):43.[doi:10.3969/j.issn.1006-1959.2018.02.015]
[2]郑 莹.COPD急诊发作常见的诱发因素进展研究[J].医学信息,2018,31(10):54.[doi:10.3969/j.issn.1006-1959.2018.10.017]
　ZHENG Ying.Research on the Common Inducing Factors of Emergency Attack in COPD[J].Journal of Medical Information,2018,31(18):54.[doi:10.3969/j.issn.1006-1959.2018.10.017]
[3]王 伟,宫秀群,余 亮.阿替普酶治疗急性脑梗死患者临床转归的影响因素[J].医学信息,2022,35(11):84.[doi:10.3969/j.issn.1006-1959.2022.11.022]
　WANG Wei,GONG Xiu-qun,YU Liang.The Influencing Factors of Clinical Outcome in Patients with Acute Cerebral Infarction Treated with Alteplase[J].Journal of Medical Information,2022,35(18):84.[doi:10.3969/j.issn.1006-1959.2022.11.022]
[4]陈建新.阿加曲班注射液治疗急性脑梗死的疗效及对血清VEGF、GLUT-1水平的影响[J].医学信息,2018,31(19):5.[doi:10.3969/j.issn.1006-1959.2018.19.002]
　CHEN Jian-xin.Effect of Argatroban Injection on Acute Cerebral Infarction and Its Effect on Serum VEGF and GLUT-1 Levels[J].Journal of Medical Information,2018,31(18):5.[doi:10.3969/j.issn.1006-1959.2018.19.002]
[5]刘 然.头颅MRI-DWI病灶数量及部位对脑梗死复发预测意义[J].医学信息,2018,31(22):172.[doi:10.3969/j.issn.1006-1959.2018.22.052]
　LIU Ran.The Significance of the Number and Location of MRI-DWI Lesions in Predicting the Recurrence of Cerebral Infarction[J].Journal of Medical Information,2018,31(18):172.[doi:10.3969/j.issn.1006-1959.2018.22.052]
[6]褚春沐.阿加曲班联合阿替普酶静脉溶栓治疗急性脑梗死的效果及对脑血管储备功能的影响[J].医学信息,2022,35(13):133.[doi:10.3969/j.issn.1006-1959.2022.13.031]
　CHU Chun-mu.Effect of Argatroban Combined with Alteplase Intravenous Thrombolysis on Acute Cerebral Infarction and its Effect on Cerebrovascular Reserve Function[J].Journal of Medical Information,2022,35(18):133.[doi:10.3969/j.issn.1006-1959.2022.13.031]
[7]徐润鸿.血府逐瘀汤联合阿托伐他汀钙治疗急性脑梗死的临床观察[J].医学信息,2019,32(05):165.[doi:10.3969/j.issn.1006-1959.2019.05.054]
　XU Run-hong.Clinical Observation on Treatment of Acute Cerebral Infarction with Xuefu Zhuyu Decoction Combined with Atorvastatin Calcium[J].Journal of Medical Information,2019,32(18):165.[doi:10.3969/j.issn.1006-1959.2019.05.054]
[8]王丹丹,王学建.动脉自旋标记在急性脑梗死中的应用[J].医学信息,2019,32(12):102.[doi:10.3969/j.issn.1006-1959.2019.12.031]
　WANG Dan-dan,WANG Xue-jian.Application of Arterial Spin Labeling in Acute Cerebral Infarction[J].Journal of Medical Information,2019,32(18):102.[doi:10.3969/j.issn.1006-1959.2019.12.031]
[9]陶 林,马 婷.丁苯酞注射液、胶囊序贯疗法辅治急性进展性脑梗死的 疗效及其对神经功能的影响[J].医学信息,2019,32(18):135.[doi:10.3969/j.issn.1006-1959.2019.18.045]
　TAO Lin,MA Ting.Efficacy of Butylphthalide Injection and Capsule Sequential Therapy in the Treatment of Acute Progressive Cerebral Infarction and Its Effect on Neurological Function[J].Journal of Medical Information,2019,32(18):135.[doi:10.3969/j.issn.1006-1959.2019.18.045]
[10]朱丽娜,王宗立,顾萌萌.UA、Hcy和FIB与颈动脉粥样硬化斑块及 脑梗死关系的分析[J].医学信息,2019,32(18):173.[doi:10.3969/j.issn.1006-1959.2019.18.061]
　ZHU Li-na,WANG Zong-li,GU Meng-meng.Analysis of the Relationship Among UA, Hcy，FIB and Carotid Atherosclerotic Plaque， Cerebral Infarction[J].Journal of Medical Information,2019,32(18):173.[doi:10.3969/j.issn.1006-1959.2019.18.061]

更新日期/Last Update: 2019-09-15